PTPN2 Regulates Iron Handling Protein Expression in Inflammatory Bowel Disease Patients and Prevents Iron Deficiency in Mice
Authors:
- Hillmin LeiHLHillmin Lei
- Ali ShawkiASAli Shawki
- Alina N. SantosASAlina N. Santos
- Vinicius CanaleVCVinicius Canale
- Salomon ManzSMSalomon Manz
- Meli’sa S. CrawfordMCMeli’sa S. Crawford
- Pritha ChatterjeePCPritha Chatterjee
- Marianne R. SpalingerMSMarianne R. Spalinger
- Michael ScharlMSMichael Scharl
- Declan F. McColeDMDeclan F. McCole
Open Access
- 3 April 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (7) , 3356
Abstract
Anemia is the most common extraintestinal manifestation of inflammatory bowel disease (IBD). Iron deficiency is the most frequent cause of anemia in IBD; however, the mechanisms involved are still poorly understood. Here, we investigated the role of the IBD risk gene, protein tyrosine phosphatase non-receptor type 2 (PTPN2), in regulating iron homeostasis. Proteomic analyses were performed on serum from IBD patients genotyped for the IBD-associated loss-of-function rs1893217 PTPN2 variant. Constitutive Ptpn2 wild type (WT), heterozygous (Het), and knockout (KO) mice were analyzed for iron content, blood parameters, and expression of iron handling proteins. Iron absorption was assessed through radiotracer assays. Serum proteomic analyses revealed that the “iron homeostasis signaling pathway” was the main pathway downregulated in Crohn’s disease (CD) patients carrying the PTPN2 risk allele, independent of disease activity. Ptpn2-KO mice showed characteristics of anemia, including reduced hemoglobin concentrations along with serum and tissue iron deficiency and elevated serum hepcidin levels vs. Ptpn2-WT and Het mice. 55Fe absorption via oral gavage was significantly impaired in Ptpn2-KO mice. Correspondingly, Ptpn2-KO mice showed reduced apical membrane expression of the iron transporter DMT1. CD patients with the PTPN2 loss-of-function rs1893217 variant display alterations in serum iron handling proteins. Loss of Ptpn2 in mice caused features of anemia, including iron deficiency associated with reduced apical membrane expression of DMT1. These findings identify an important role for PTPN2 in regulating systemic iron homeostasis.Keywords
Funding Information
- NIH/NIAID (R21AI152017)
- NIH (2R01-DK091281, 1R01AI153314-01, 1R01DK138456-01)
- Swiss National Science Foundation Advanced Postdoctoral Mobility Grant (177932)
- UCR-City of Hope CUBRI Award (2016)
This publication has 59 references indexed in Scilit:
- Apolipoprotein E is required for brain iron homeostasis in miceRedox Biology, 2023
- Basics and principles of cellular and systemic iron homeostasisMolecular Aspects of Medicine, 2020
- Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2020
- Hepcidin is a key mediator of anemia of inflammation in Crohn's diseaseJournal of Crohn's and Colitis, 2013
- Hepcidin and iron homeostasisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Diagnosing anemia in inflammatory bowel disease: Beyond the established markersJournal of Crohn's and Colitis, 2011
- Protein Tyrosine Phosphatase non-Receptor Type 2 regulates IFN-γ-induced cytokine signaling in THP-1 monocytesInflammatory Bowel Diseases, 2010
- Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cellsFEBS Letters, 2004
- Hemopexin: a review of biological aspects and the role in laboratory medicineClinica Chimica Acta, 2001
- The T-cell protein tyrosine phosphataseSeminars in Immunology, 2000